Skip to content

Inguinal Hernia Study Using Biodesign IHM

Inguinal Hernia Study: A Double Blinded Randomized Prospective Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00393887
Enrollment
100
Registered
2006-10-30
Start date
2007-03-31
Completion date
2014-06-30
Last updated
2015-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

Inguinal hernia, polypropylene, Biodesign IHM, lichtenstein

Brief summary

Aim is to evaluate outcomes of inguinal hernia repair incorporating the standard Lichtenstein (open) repair using Biodesign IHM in a double blind (physician evaluator and patient will be blinded), randomized, prospective comparative study with polypropylene mesh. Primary outcome is recurrence at 1 year. Hernia recurrence will be confirmed via ultrasound or CT scan.

Interventions

DEVICEBiodesign IHM

Biodesign IHM is placed to reinforce the hernia repair

Polypropylene mesh is used to reinforce the hernia repair.

Sponsors

Cook Biotech Incorporated
CollaboratorINDUSTRY
MED Institute, Incorporated
CollaboratorINDUSTRY
Cook Group Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age * Diagnosis of Unilateral inguinal hernia repair * Able to provide written consent

Exclusion criteria

* Incarcerated hernia * Allergic or religious beliefs that disallow porcine material * Previous hernia repair on the designated hernia site * Class IV or V anesthesia requirements * Bowel obstruction * Peritonitis * Life expectancy \< 3 years

Design outcomes

Primary

MeasureTime frame
Number of Patients With Inguinal Hernia Recurrence1 year

Countries

United States

Participant flow

Participants by arm

ArmCount
Biodesign IHM Graft
Biodesign Inguinal Hernia Matrix (IHM)
50
Polypropylene Mesh
Synthetic polypropylene mesh
50
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up119
Overall StudyPhysician Decision50

Baseline characteristics

CharacteristicBiodesign IHM GraftPolypropylene MeshTotal
Age, Continuous64 years59 years61.5 years
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
50 Participants50 Participants100 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
18 / 4515 / 50
serious
Total, serious adverse events
7 / 455 / 50

Outcome results

Primary

Number of Patients With Inguinal Hernia Recurrence

Time frame: 1 year

ArmMeasureValue (NUMBER)
Biodesign IHM GraftNumber of Patients With Inguinal Hernia Recurrence3 participants
Polypropylene MeshNumber of Patients With Inguinal Hernia Recurrence0 participants
Comparison: Two-sided Fisher's exact testp-value: 0.11Fisher Exact

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026